Acitrom Tablet (Acenocoumarol)
Acitrom 2 Tablet is an oral anticoagulant that helps prevent harmful blood clots in the legs, lungs, brain, and heart. It is used for deep vein thrombosis, pulmonary embolism, and stroke prevention.Acitrom 2 Tablet should be taken as advised by the doctor. You may take it with or without food but it is better to take it at a fixed time. This medicine should not be stopped abruptly without consulting the doctor. You should take this medicine regularly to get the most benefit, even if you feel fine. It is preventing future harm.
$48.00 – $196.00
Description
Acitrom 2 Tablet is an oral anticoagulant that helps prevent harmful blood clots in the legs, lungs, brain, and heart. It is used for deep vein thrombosis, pulmonary embolism, and stroke prevention.
Acitrom 2 Tablet should be taken as advised by the doctor. You may take it with or without food but it is better to take it at a fixed time. This medicine should not be stopped abruptly without consulting the doctor. You should take this medicine regularly to get the most benefit, even if you feel fine. It is preventing future harm.
Use of this medicine may increase your risk of bleeding. Let your doctor know immediately if you see a pinpoint rash or blood in your vomits, urine, or stool. If you are going under any surgery or dental treatment, you may need to stop this medicine for some time but only after consulting with your doctor.
Before taking it, you must inform the doctor if you are suffering from any kidney or liver disease. Also, let your doctor know if you are pregnant or breastfeeding and about all the other medications that you are taking regularly.
USES OF ACITROM TABLET
- Treatment and prevention of Blood clots
BENEFITS OF ACITROM TABLET
In Treatment and prevention of Blood clots
SIDE EFFECTS OF ACITROM TABLET
Common side effects of Acitrom
- Hemorrhage
HOW TO USE ACITROM TABLET
HOW ACITROM TABLET WORKS
Additional information
Strength | 2 mg |
---|---|
Pack Size | 30 Tablets, 60 Tablets, 90 Tablets |
Reviews
There are no reviews yet.